Close
ACHEMA MIDDLE EAST 2026
DDF Summit 2025

News

      Eli Lilly Unveils Lilly TuneLab for AI-driven Drug Discovery

      Drug Development
      Eli Lilly and Company has officially introduced the Lilly TuneLab AI platform, a new artificial intelligence and machine learning system designed to give biotechnology...

      FDA Approves Recombinant VWF Treatment in Pediatric Patients

      Drug Development
      The US Food and Drug Administration (FDA) has expanded the indication for recombinant von Willebrand factor (VWF), marketed as Vonvendi, to include children with...

      Novartis and Argo Signs Deal of up to $5.2b for Heart Drugs

      Drug Development
      Swiss pharmaceutical leader Novartis has entered into a cardiovascular drug licensing deal valued at up to $5.2 billion with China-based Argo Biopharmaceutical. The deal...

      Mod GRF 1-29 Peptide: Investigating Its Potential in Scientific Research

      News
      The Mod GRF 1-29 peptide has garnered attention in scientific research due to its hypothesized role in regulating growth hormone. As a modified analog...

      MGI Tech and JCBio Advance Multi-Omics with DCS Lab Project

      Asia
      MGI Tech Co., Ltd., a developer of advanced life sciences technologies, and JCBio Co., Ltd., a biotechnology company in South Korea, have entered into...

      Novartis and Arrowhead Sign Deal to Advance Parkinson’s Drug

      Drug Development
      Novartis has renewed its focus on Parkinson’s disease through a significant collaboration with Arrowhead Pharmaceuticals, marking another strategic step into neuroscience drug development. The...

      FDA Approves Eisai’s Leqembi IQLIK for Alzheimer’s Treatment

      Americas
      Eisai has achieved an important regulatory milestone as the FDA approves Leqembi IQLIK, strengthening the company’s long-term plans to expand the medicine’s use in...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      © 2025 Copyright © Valuemediaservices 2025 All rights reserved.